Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Ruiz

Showing results (581-590 of 645) with videos related to

Pageof 65
Sort By:
Scientific Reports|June 21, 2022
Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19Rosario López-Rodríguez, Marta Del Pozo-Valero, Marta Corton, et al.
The Lancet. Infectious Diseases|September 16, 2022
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trialKarin Hardt, An Vandebosch, Jerald Sadoff, et al.
Nature Biomedical Engineering|January 5, 2021
A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burdenJoseph D Butner, Zhihui Wang, Dalia Elganainy, et al.
Medicina Clinica|February 16, 2017
Opportunistic screening for atrial fibrillation versus detecting symptomatic patients aged 65 years and older: A cluster-controlled clinical trialVirginia González Blanco, Luis Ángel Pérula de Torres, Enrique Martín Rioboó, et al.
Vaccine|June 6, 2022
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trialsJerald Sadoff, Mathieu Le Gars, Boerries Brandenburg, et al.
Journal of the American Chemical Society|December 10, 2024
Interfacial Reactivity-Triggered Oscillatory Lattice Strains of NanoalloysZhi-Peng Wu, Dong Dinh, Yazan Maswadeh, et al.
Biomolecules|November 25, 2023
Placentas from Women with Late-Onset Preeclampsia Exhibit Increased Expression of the NLRP3 Inflammasome MachineryLuis M Garcia-Puente, Oscar Fraile-Martinez, Cielo García-Montero, et al.
Plos One|February 26, 2016
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical ResectionClara Bayarri-Lara, Francisco G Ortega, Antonio Cueto Ladrón de Guevara, et al.
Cancers|March 6, 2021
The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In VivoBegoña Alburquerque-González, Ángel Bernabé-García, Manuel Bernabé-García, et al.
Journal of Clinical Medicine|October 14, 2023
Red Blood Cell Transfusion after Postpartum Hemorrhage: Clinical Variables Associated with Lack of Postpartum Hemorrhage Etiology IdentificationFrancisco Javier Ruiz-Labarta, Rocío Aracil Rodríguez, Ainoa Sáez Prat, et al.
Pageof 65

Showing results (581-590 of 645) with videos related to

Sort By:
Pageof 65
Scientific Reports|June 21, 2022
Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19Rosario López-Rodríguez, Marta Del Pozo-Valero, Marta Corton, et al.
The Lancet. Infectious Diseases|September 16, 2022
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trialKarin Hardt, An Vandebosch, Jerald Sadoff, et al.
Nature Biomedical Engineering|January 5, 2021
A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burdenJoseph D Butner, Zhihui Wang, Dalia Elganainy, et al.
Medicina Clinica|February 16, 2017
Opportunistic screening for atrial fibrillation versus detecting symptomatic patients aged 65 years and older: A cluster-controlled clinical trialVirginia González Blanco, Luis Ángel Pérula de Torres, Enrique Martín Rioboó, et al.
Vaccine|June 6, 2022
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trialsJerald Sadoff, Mathieu Le Gars, Boerries Brandenburg, et al.
Journal of the American Chemical Society|December 10, 2024
Interfacial Reactivity-Triggered Oscillatory Lattice Strains of NanoalloysZhi-Peng Wu, Dong Dinh, Yazan Maswadeh, et al.
Biomolecules|November 25, 2023
Placentas from Women with Late-Onset Preeclampsia Exhibit Increased Expression of the NLRP3 Inflammasome MachineryLuis M Garcia-Puente, Oscar Fraile-Martinez, Cielo García-Montero, et al.
Plos One|February 26, 2016
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical ResectionClara Bayarri-Lara, Francisco G Ortega, Antonio Cueto Ladrón de Guevara, et al.
Cancers|March 6, 2021
The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In VivoBegoña Alburquerque-González, Ángel Bernabé-García, Manuel Bernabé-García, et al.
Journal of Clinical Medicine|October 14, 2023
Red Blood Cell Transfusion after Postpartum Hemorrhage: Clinical Variables Associated with Lack of Postpartum Hemorrhage Etiology IdentificationFrancisco Javier Ruiz-Labarta, Rocío Aracil Rodríguez, Ainoa Sáez Prat, et al.
Pageof 65